Literature DB >> 1459726

The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous-cell carcinoma.

E Sakai1, K Rikimaru, M Ueda, Y Matsumoto, N Ishii, S Enomoto, H Yamamoto, N Tsuchida.   

Abstract

The frequencies of mutations in the p53 tumor-suppressor gene and ras proto-oncogenes were investigated systematically in surgically resected oral squamous-cell carcinomas (SCCs) using single-strand conformation polymorphism (SSCP) and/or dot-blot hybridization analysis of DNA fragments which had been amplified by the polymerase chain reaction (PCR). p53 gene mutations, within the region of exons 5 to 8, were detected in 17 out of 27 (63%) tumor specimens. The role of p53 mutations in cell-line establishment was investigated. p53 gene mutations were detected in 5 out of 6 tissue samples from which cell lines were established and in 4 out of 5 specimens from which cell lines could not be established, suggesting that the presence of p53 gene mutations is not by itself sufficient for cell-line establishment. Tumor samples were also analyzed for point mutational activation of the ras proto-oncogenes. One out of 30 (3%) tumors showed an activating point mutation in codon 12 of H-ras, this being consistent with reports from Europe and USA but not with any from India. Compared to frequencies of the other genetic changes so far reported for oral SCC, the p53 mutations have been observed most often to undergo genetic change. p53 gene mutation is thus intimately involved in the genesis of oral SCC and consequently should be useful as a marker for the diagnosis of this neoplasm.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1459726     DOI: 10.1002/ijc.2910520606

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Expression of ets-1 is not affected by N-ras or H-ras during oral oncogenesis.

Authors:  Eleftherios Vairaktaris; Georgios Papageorgiou; Spyridoula Derka; Panagiota Moulavassili; Emeka Nkenke; Peter Kessler; Stavros Vassiliou; Veronica Papakosta; Sofia Spyridonidou; Antonis Vylliotis; Andreas C Lazaris; Sofia Anagnostopoulou; Constantinos Mourouzis; Christos Yapijakis; Efstratios Patsouris
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-28       Impact factor: 4.553

2.  DNA profiling of B chromosomes from the yellow-necked mouse Apodemus flavicollis (Rodentia, Mammalia).

Authors:  N Tanic; N Dedovic; M Vujosevic; B Dimitrijevic
Journal:  Genome Res       Date:  2000-01       Impact factor: 9.043

Review 3.  The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.

Authors:  J K Field
Journal:  J R Soc Med       Date:  1995-01       Impact factor: 5.344

4.  Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.

Authors:  Xiaoyong Fan; Hongzhen Lu; Youqiang Cui; Xianzeng Hou; Chuanjiang Huang; Guangcun Liu
Journal:  Exp Ther Med       Date:  2018-03-08       Impact factor: 2.447

5.  Expression of Nur77 induced by an n-butylidenephthalide derivative promotes apoptosis and inhibits cell growth in oral squamous cell carcinoma.

Authors:  Po Yen Liu; Jim Jinn-Chyuan Sheu; Po Cheng Lin; Cheng Tung Lin; Ya Jung Liu; Li Ing Ho; Li Fu Chang; Wan Chen Wu; Syue Rong Chen; Jay Chen; Yeu Chern Harn; Shinn Zong Lin; Chang Hai Tsai; Tzyy Wen Chiou; Horng Jyh Harn
Journal:  Invest New Drugs       Date:  2010-09-01       Impact factor: 3.850

6.  Malignant conversion of chemically transformed normal human cells.

Authors:  G E Milo; D Li; B C Casto; K Theil; C Shuler; I Noyes; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

7.  Oncogenes and tumor suppressor genes in squamous cell carcinoma of the tongue in young patients.

Authors:  Andreas Knopf; Justine Lempart; Murat Bas; Julia Slotta-Huspenina; Naglaa Mansour; Marie Kristin Fritsche
Journal:  Oncotarget       Date:  2015-02-20

8.  Long non-coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p.

Authors:  Yong Du; Haiyan Yang; Yue Li; Wenli Guo; Yufeng Zhang; Haitao Shen; Lingxiao Xing; Yuehong Li; Wenxin Wu; Xianghong Zhang
Journal:  Cell Oncol (Dordr)       Date:  2021-04-02       Impact factor: 6.730

9.  Co-culture with lung cancer A549 cells promotes the proliferation and migration of mesenchymal stem cells derived from bone marrow.

Authors:  Yue-Mei Zhang; Zhi-Ming Zhang; Quan-Lin Guan; Yong-Qi Liu; Zhi-Wei Wu; Jin-Tian Li; Yun Su; Chun-Lu Yan; Ya-Li Luo; Jie Qin; Qian Wang; Xiao-Dong Xie
Journal:  Exp Ther Med       Date:  2017-08-08       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.